Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Toda

Showing results (41-50 of 195) with videos related to

Pageof 20
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 10, 1993
[Physiopathology of autoimmune liver diseases]G Toda, M Zeniya
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1994
[Primary biliary cirrhosis (PBC): concept, pathogenesis and classification]Y Aizawa, G Toda
Journal of Gastroenterology and Hepatology|August 2, 2000
Case selection for interferon treatment of hepatitis CM Zeniya, G Toda
Internal Medicine (Tokyo, Japan)|May 9, 2000
Autoimmune liver disease: current therapyM Zeniya, G Toda
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 1995
[Nucleotide mutations in the precore and core region of hepatitis B virus]T Karasawa, G Toda
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 10, 1991
[Liver cirrhosis with unusual etiology not to be ignored]Y Ikeda, G Toda
Ryoikibetsu Shokogun Shirizu|January 1, 1997
[Kidney in chronic active hepatitis]M Zeniya, G Toda
Biochemical and Biophysical Research Communications|May 29, 1987
Effects of teleocidin on the morphology and c-myc expression of hepatoma cells which are not inhibited by protein kinase antagonistsY Kaneko, G Toda, H Oka
Journal of Gastroenterology and Hepatology|May 1, 1992
Selectivity of serum immunoreactive prolyl 4-hydroxylase as a marker for hepatic necrosisY Nagai, M Kato, G Toda
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2002
[Hepatocellular carcinoma without hepatitis virus markers]M Itsubo, A Saito, G Toda
Pageof 20

Showing results (41-50 of 195) with videos related to

Sort By:
Pageof 20
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 10, 1993
[Physiopathology of autoimmune liver diseases]G Toda, M Zeniya
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1994
[Primary biliary cirrhosis (PBC): concept, pathogenesis and classification]Y Aizawa, G Toda
Journal of Gastroenterology and Hepatology|August 2, 2000
Case selection for interferon treatment of hepatitis CM Zeniya, G Toda
Internal Medicine (Tokyo, Japan)|May 9, 2000
Autoimmune liver disease: current therapyM Zeniya, G Toda
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 1995
[Nucleotide mutations in the precore and core region of hepatitis B virus]T Karasawa, G Toda
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 10, 1991
[Liver cirrhosis with unusual etiology not to be ignored]Y Ikeda, G Toda
Ryoikibetsu Shokogun Shirizu|January 1, 1997
[Kidney in chronic active hepatitis]M Zeniya, G Toda
Biochemical and Biophysical Research Communications|May 29, 1987
Effects of teleocidin on the morphology and c-myc expression of hepatoma cells which are not inhibited by protein kinase antagonistsY Kaneko, G Toda, H Oka
Journal of Gastroenterology and Hepatology|May 1, 1992
Selectivity of serum immunoreactive prolyl 4-hydroxylase as a marker for hepatic necrosisY Nagai, M Kato, G Toda
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2002
[Hepatocellular carcinoma without hepatitis virus markers]M Itsubo, A Saito, G Toda
Pageof 20